2021
Date: | ||
Time: | ||
Location: | Webcast Link – or at the company’s website (click here) |
Oppenheimer Rare & Orphan Disease Summit
Date: | ||
Time: | ||
Location: | Webcast Link – or at the company’s website (click here) |
About
For more information, visit https://www.gaintherapeutics.com/
Forward-Looking Statements
Any statements in this release that are not historical facts may be considered to be “forward-looking statements.” Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein. Such statements include, but are not limited to, statements regarding the market opportunity for Gain’s product candidates; and the business strategies and development plans of Gain. Some of the potential risks and uncertainties that could cause actual results to differ from those expected include Gain’s ability to: make commercially available its products and technologies in a timely manner or at all; enter into other strategic alliances, including arrangements for the development and distribution of its products; obtain intellectual property protection for its assets; accurately estimate its expenses and cash burn and raise additional funds when necessary. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, Gain does not undertake any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
Investor Contact:
+1 617-430-7576
daniel@lifesciadvisors.com
Media Contact:
+1 646-751-4366
mjoanis@lifescicomms.com
Source:
2021 GlobeNewswire, Inc., source